This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Georg-August-Universitat Gottingen Stiftung Des Offentlichen Rechts. Active years: 2012-2018.
Location History:
- Göttingen, DE (2013)
- Goettingen, DE (2012 - 2018)
Company Filing History:
4 out of 1,328 
1 out of 1 Years Active: 2012-2018
Title: Henning Urlaub: Innovator in RNA-Interference Technology
Introduction
Henning Urlaub is a prominent inventor based in Goettingen, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of RNA-interference technology. With a total of 4 patents to his name, Urlaub's work has advanced our understanding of gene regulation and therapeutic applications.
Latest Patents
Among his latest patents, Urlaub has developed innovative methods related to RNA-interference by single-stranded RNA molecules. His inventions focus on the sequence and structural features of single-stranded (ss)RNA molecules that are essential for mediating target-specific nucleic acid modifications through RNA-interference (RNAi). This includes processes such as target mRNA degradation and DNA methylation, which are crucial for gene silencing and regulation.
Career Highlights
Throughout his career, Henning Urlaub has been associated with esteemed institutions such as the Max Planck Society for the Advancement of Science and the Georg-August-University Göttingen. His work in these organizations has allowed him to explore and develop groundbreaking technologies that have implications in both research and clinical settings.
Collaborations
Urlaub has collaborated with notable scientists in his field, including Thomas Tuschl and Javier Martinez. These partnerships have fostered a collaborative environment that has led to significant advancements in RNA research and its applications.
Conclusion
Henning Urlaub's contributions to RNA-interference technology exemplify the impact of innovative thinking in the field of molecular biology. His patents and collaborations continue to influence research and development in gene regulation.